Arizona State Retirement System’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-34,448
Closed -$52K 2205
2023
Q1
$52K Buy
34,448
+5,487
+19% +$13.7K ﹤0.01% 2186
2022
Q4
$72.4K Sell
28,961
-3,271
-10% -$10.5K ﹤0.01% 2158
2022
Q3
$135K Buy
32,232
+4,552
+16% +$17.8K ﹤0.01% 2029
2022
Q2
$77K Buy
27,680
+1,503
+6% +$6.04K ﹤0.01% 2162
2022
Q1
$150K Buy
26,177
+120
+0.5% +$878 ﹤0.01% 2081
2021
Q4
$238K Sell
26,057
-294
-1% -$3K ﹤0.01% 1980
2021
Q3
$282K Buy
26,351
+2,749
+12% +$33.5K ﹤0.01% 1875
2021
Q2
$366K Sell
23,602
-1,524
-6% -$24.2K ﹤0.01% 1753
2021
Q1
$407K Buy
25,126
+95
+0.4% +$1.69K ﹤0.01% 1646
2020
Q4
$530K Sell
25,031
-951
-4% -$16.5K ﹤0.01% 1417
2020
Q3
$385K Buy
25,982
+6,673
+35% +$104K ﹤0.01% 1460
2020
Q2
$284K Sell
19,309
-775
-4% -$12.7K ﹤0.01% 1459
2020
Q1
$236K Buy
+20,084
New +$378K ﹤0.01% 1426

Other funds holding HRTX

Arizona State Retirement System's HRTX Position: Q2 2023 in Review

Arizona State Retirement System sold out of Heron Therapeutics (HRTX) in Q2 2023, closing a stake of 34,448 shares — an estimated $52K sold.

Arizona State Retirement System first reported a position in HRTX in Q1 2020 and held it in 13 quarters. The position peaked at $530K in Q4 2020. 149 funds tracked by Wall St. Rank hold HRTX as of Q2 2023.

  • Arizona State Retirement System reported no remaining Heron Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Arizona State Retirement System sold 34,448 Heron Therapeutics shares in Q2 2023, an estimated $52K.
  • Arizona State Retirement System first reported a position in Heron Therapeutics in Q1 2020 and held it in 13 quarters.
  • Arizona State Retirement System's Heron Therapeutics position peaked at $530K in Q4 2020.
  • 149 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2023.

Based on Arizona State Retirement System's 13F filing for Q2 2023, filed 1 Aug 2023.